- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | COVID-19 Vaccine of the Vector Center has Shown High Efficiency in Preclinical Trials | ||
| Di | AstraZeneca Begins Human Trials of COVID-19 Antibody Treatment | ||
| Di | Domestic Sales of Chinese Vaccines rise, Breaking the Monopoly of Western Corporations | ||
| Di | Belarus would Be the First Country to Be Supplied with the Russian-made COVID-19 Vaccine | ||
| Di | 50% of Participants in the Second Phase of Novavax Vaccine Trials will Be over 60 Years Old | ||
| Di | Kohlberg & Co and Mubadala Acquire Controlling Interest in PCI Pharma | ||
| Di | EC Completes Negotiations with Moderna to Supply 80 Million Doses of COVID-19 Vaccine | ||
| Di | Where and how to register biosimilars? World experience | ||
| Mo | Teva will Cut 350 Manufacturing Jobs in Israel | ||
| Mo | Italy Begins Clinical Trials on Volunteers of its Coronavirus Vaccine | ||
| Mo | Catalent to Provide AstraZeneca's Covid-19 Vaccine Substance | ||
| Mo | The Recall from the Metformin Market Continues, Due to the Detection of NDMA in the Drug | ||
| Mo | China has Authorized Emergency Use of COVID-19 Vaccine Back in July | ||
| Mo | Chumakov Center Applies for Clinical Tests of its COVID-19 Vaccine | ||
| Mo | FDA Issues EUA for Convalescent Plasma as Potential Promising COVID-19 Treatment | ||
| Mo | Takeda to Sell Consumer Healthcare Business to Blackstone for $ 2.3 Billion | ||
| So | FDA Approves New Carfilzomib Combination Regimen with Daratumumab and Dexamethasone | ||
| Fr | FUJIFILM Diosynth Biotechnologies Started Building Innovation Center in USA | ||
| Fr | More than 560,000 Pouches of Birth Control Pills are Recalling from the US Market | ||
| Fr | Clinical Trials of the EpiVacCorona Vaccine are Planned to Be Completed in September 2020 | ||
| Fr | COVID-19: New Data Indicate High Immunogenicity of Pfizer-Oxford Vaccine | ||
| Fr | World's Largest Database of T and B Cell Receptor Sequencing of Coronavirus Patients | ||
| Fr | FDA Approves Ofatumumab, the only Self-administered, Targeted B-cell Therapy for Patients with RMS | ||
| Fr | Bayer will Pay $ 1.6 Billion to Settle US Claims in Essure Case | ||
| Do | China Has Developed a Encephalitis Vaccine that Protects against Two Deadly Diseases |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
